BSEBandaram Pharma Packtech Ltd· Healthcare ServicesHighNegative
Announced Tue, 1 Apr, 2025 · 10:41 IST

The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on March 29, 2025 for B. Deepak Reddy

Pledge ReleasedPromoter Below 50pctOwnership Changes View source PDFExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
—Next day
—
prior close
₹46.37
announcement price
In-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used——
Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.0
10m
+0.0
15m
+0.0
30m
+0.0
Sessions after the filingfrom the prior close
StockMarketvs market
Reaction day
———
Next day
———
2d
———
3d
———
4d
———
5d
———
1w
———
15d
———
1m
———
2m
———
3m
———
UpDownMarket · Nifty Microcap 250Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Promoter and Chairman & Managing Director B. Deepak Reddy has released a pledge on 2,10,000 shares, equal to 1.75% of the company's total share capital. The release took place on December 5, 2024, and the reason cited is repayment of a loan, meaning the entire previously pledged stake has been freed from encumbrance. B. Deepak Reddy continues to hold 47,25,000 shares (39.38% of total share capital) in the company. This is a revised disclosure filed with BSE on March 29, 2025, in response to the exchange seeking further details on the original encumbrance disclosure.

Likely market impact

Positive signal for shareholders — the full release of pledged shares indicates the promoter has cleared the underlying loan obligation, reducing pledge-related risk and improving transparency on the promoter's encumbered holdings.